Tag Archives: Best Practices

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 4 of New Series

Author:

Let’s be real, 2020 has been a hard year. It’s hard to know what to do or what not to do; it’s hard to navigate business decisions, when it’s NOT business as usual. We want you to know that while

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 3 of New Series

Author:

Let’s be real, 2020 has been a difficult year thus far. We see people hunkering down, their focus shifting and some reticence to make decisions. Best Practices has felt these seismic shifts as well, but one thing that has not

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 2 of New Series

Author:

2020 has been a difficult year, but the need for speed in making business decision is becoming more critical. Best Practices recognizes that seismic shifts in how business is conducted are facing all companies, and we want to re-confirm our

When Personal and Professional Experiences Meet, Our Clients Benefit: Part 1 of New Series

Author:

Let’s be real, 2020 has been a hard year for most of us. It’s hard to know what to do or what not to do; it’s hard to navigate business decisions, when it’s NOT business as usual. We see people

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Apple’s announcement for AC Wellness follows on the heels of

Brand Lifecycle Management: Strategies for Every Budget

At every investment level, superior strategies emerge Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels

Evidence-based Tactics Impact TRx Growth

Co-pay and adherence programs continue to be the most effective tactics to drive TRx pull through Many pharmaceutical companies use co-pay cards and adherence programs as individual tactics in their patient support programs, but health care consultancies Best Practices, LLC

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Author:

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It

“Troubleshooting” a Key Challenge of the Global Branding Process for New Bio-Pharma Products: Alignment Across Geographies

In the bio-pharmaceutical industry, it is no secret that different regions of the world have diverse regulatory and cultural environments. What is less apparent is that given these regional regulatory and cultural differences, pharmaceutical companies can have an effective global

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Much like many animals

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

Take a look at the slide below and see if you can answer which of the 5 drugs had a peak sales year of $13.7 billion. The answer? – Lipitor While Lipitor sold a gigantic $13.7 billion in their peak sales year,

Hotspots in Biopharma Digital Marketing Innovation

The rapid growth of digital, mobile and related technologies has transformed the global communications paradigm, and with it, changed the ways in which consumers and professionals access information. In case of the biopharmaceutical and medical device industry, the development of